Exagen to announce first quarter 2024 results on may 13, 2024

Carlsbad, calif., april 30, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing, will release financial results for the quarter ended march 31, 2024, before the market opens on monday, may 13, 2024. john aballi, exagen's president and chief executive officer, and kamal adawi, chief financial officer, will host a conference call to review the company's results at 8:30 am et (5:30 am pt).
XGN Ratings Summary
XGN Quant Ranking